Buscar
Mostrando ítems 1-10 de 5868
Management of technological innovation: Case studies in biotechnology companies in Brazil
(2011)
Purpose - The aim of this paper is to contribute to understanding of the process of innovation in the biotechnology companies operating in Brazil. The paper identifies the most critical factors in the innovation process ...
Foresight and Big Data
(CIMMYT, 2019)
Biotechnology for Clean Industrial Products and Processes. Towards Industrial Sustainability
(1998)
Industrial biotechnology has come of age: after decades spent in the shadow of two better-known fields, health and agro-food biotechnology, it has emerged into a world where environmental sustainability has become a global ...
An immunological strategy to monitor in situ the phosphate starvation state in Thiobacillus ferrooxidans
(1998)
Thiobacillus ferrooxidans is one of the chemolithoautotrophic bacteria important in industrial biomining operations. During the process of ore bioleaching, the microorganisms are subjected to several stressing conditions, ...
An immunological assay for detection and enumeration of thermophilic biomining microorganisms
(1994)
A specific, fast, and sensitive nonradioactive immunobinding assay for the detection and enumeration of the moderate thermophile Thiobacillus caldus and the thermophilic archaeon Sulfolobus acidocaldarius was developed. ...
A nationwide biotechnology outreach and awareness program for Malaysian high schools
(Pontificia Universidad Católica de Valparaíso, 2005)
Optimization of a biotechnological multiproduct batch plant design for the manufacture of four different products: a real case scenario
(John Wiley, 2017)
In this work a biotechnological multiproduct batch plant
that manufactures four different recombinant proteins for human
application is described in some detail. This batch plant design is then
optimized with regards ...
Biopharmaceuticals from microorganisms: from production to purification
(2016-12-01)
The use of biopharmaceuticals dates from the 19th century and within 5–10 years, up to 50% of all drugs in development will be biopharmaceuticals. In the 1980s, the biopharmaceutical industry experienced a significant ...